225 related articles for article (PubMed ID: 16247446)
1. Prevention of lung cancer progression by bexarotene in mouse models.
Wang Y; Zhang Z; Yao R; Jia D; Wang D; Lubet RA; You M
Oncogene; 2006 Mar; 25(9):1320-9. PubMed ID: 16247446
[TBL] [Abstract][Full Text] [Related]
2. Mice with alterations in both p53 and Ink4a/Arf display a striking increase in lung tumor multiplicity and progression: differential chemopreventive effect of budesonide in wild-type and mutant A/J mice.
Wang Y; Zhang Z; Kastens E; Lubet RA; You M
Cancer Res; 2003 Aug; 63(15):4389-95. PubMed ID: 12907609
[TBL] [Abstract][Full Text] [Related]
3. A mouse model for tumor progression of lung cancer in ras and p53 transgenic mice.
Wang Y; Zhang Z; Lubet RA; You M
Oncogene; 2006 Feb; 25(8):1277-80. PubMed ID: 16247444
[TBL] [Abstract][Full Text] [Related]
4. The retinoid X receptor agonist bexarotene (Targretin) synergistically enhances the growth inhibitory activity of cytotoxic drugs in non-small cell lung cancer cells.
Hermann TW; Yen WC; Tooker P; Fan B; Roegner K; Negro-Vilar A; Lamph WW; Bissonnette RP
Lung Cancer; 2005 Oct; 50(1):9-18. PubMed ID: 15993980
[TBL] [Abstract][Full Text] [Related]
5. Modulation by bexarotene of mRNA expression of genes in mouse lung tumors.
Alyaqoub FS; Liu Y; Tao L; Steele VE; Lubet RA; Pereira MA
Mol Carcinog; 2008 Mar; 47(3):165-71. PubMed ID: 17849452
[TBL] [Abstract][Full Text] [Related]
6. Cancer chemopreventive activity of a mixture of Chinese herbs (antitumor B) in mouse lung tumor models.
Zhang Z; Wang Y; Yao R; Li J; Yan Y; La Regina M; Lemon WL; Grubbs CJ; Lubet RA; You M
Oncogene; 2004 May; 23(21):3841-50. PubMed ID: 15021904
[TBL] [Abstract][Full Text] [Related]
7. A selective retinoid X receptor agonist bexarotene (Targretin) prevents and overcomes acquired paclitaxel (Taxol) resistance in human non-small cell lung cancer.
Yen WC; Corpuz MR; Prudente RY; Cooke TA; Bissonnette RP; Negro-Vilar A; Lamph WW
Clin Cancer Res; 2004 Dec; 10(24):8656-64. PubMed ID: 15623650
[TBL] [Abstract][Full Text] [Related]
8. Aerosolized bexarotene inhibits lung tumorigenesis without increasing plasma triglyceride and cholesterol levels in mice.
Zhang Q; Pan J; Zhang J; Liu P; Chen R; Chen DR; Lubet R; Wang Y; You M
Cancer Prev Res (Phila); 2011 Feb; 4(2):270-6. PubMed ID: 21163938
[TBL] [Abstract][Full Text] [Related]
9. Ki-ras and p53 mutations are early and late events, respectively, in urethane-induced pulmonary carcinogenesis in A/J mice.
Horio Y; Chen A; Rice P; Roth JA; Malkinson AM; Schrump DS
Mol Carcinog; 1996 Dec; 17(4):217-23. PubMed ID: 8989915
[TBL] [Abstract][Full Text] [Related]
10. Emerging role of rexinoids in non-small cell lung cancer: focus on bexarotene.
Rigas JR; Dragnev KH
Oncologist; 2005 Jan; 10(1):22-33. PubMed ID: 15632250
[TBL] [Abstract][Full Text] [Related]
11. Lack of efficacy of the statins atorvastatin and lovastatin in rodent mammary carcinogenesis.
Lubet RA; Boring D; Steele VE; Ruppert JM; Juliana MM; Grubbs CJ
Cancer Prev Res (Phila); 2009 Feb; 2(2):161-7. PubMed ID: 19196723
[TBL] [Abstract][Full Text] [Related]
12. Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes.
Fisher GH; Wellen SL; Klimstra D; Lenczowski JM; Tichelaar JW; Lizak MJ; Whitsett JA; Koretsky A; Varmus HE
Genes Dev; 2001 Dec; 15(24):3249-62. PubMed ID: 11751631
[TBL] [Abstract][Full Text] [Related]
13. The differential effects of mutant p53 alleles on advanced murine lung cancer.
Jackson EL; Olive KP; Tuveson DA; Bronson R; Crowley D; Brown M; Jacks T
Cancer Res; 2005 Nov; 65(22):10280-8. PubMed ID: 16288016
[TBL] [Abstract][Full Text] [Related]
14. Alteration of microRNA expression in vinyl carbamate-induced mouse lung tumors and modulation by the chemopreventive agent indole-3-carbinol.
Melkamu T; Zhang X; Tan J; Zeng Y; Kassie F
Carcinogenesis; 2010 Feb; 31(2):252-8. PubMed ID: 19748927
[TBL] [Abstract][Full Text] [Related]
15. Molecular comparison of human and mouse pulmonary adenocarcinomas.
Malkinson AM
Exp Lung Res; 1998; 24(4):541-55. PubMed ID: 9659582
[TBL] [Abstract][Full Text] [Related]
16. Induction of invasive mouse skin carcinomas in transgenic mice with mutations in both H-ras and p53.
Zhang Z; Yao R; Li J; Wang Y; Boone CW; Lubet RA; You M
Mol Cancer Res; 2005 Oct; 3(10):563-74. PubMed ID: 16254190
[TBL] [Abstract][Full Text] [Related]
17. Expression of human Krev-1 gene in lungs of transgenic mice and subsequent reduction in multiplicity of ethyl carbamate-induced lung adenomas.
Damak S; Harnboonsong Y; George PM; Bullock DW
Mol Carcinog; 1996 Oct; 17(2):84-91. PubMed ID: 8890957
[TBL] [Abstract][Full Text] [Related]
18. Loss of p53 in craf-induced transgenic lung adenoma leads to tumor acceleration and phenotypic switch.
Fedorov LM; Papadopoulos T; Tyrsin OY; Twardzik T; Götz R; Rapp UR
Cancer Res; 2003 May; 63(9):2268-77. PubMed ID: 12727849
[TBL] [Abstract][Full Text] [Related]
19. Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene.
Tao Q; Fujimoto J; Men T; Ye X; Deng J; Lacroix L; Clifford JL; Mao L; Van Pelt CS; Lee JJ; Lotan D; Lotan R
J Natl Cancer Inst; 2007 Nov; 99(22):1668-82. PubMed ID: 18000218
[TBL] [Abstract][Full Text] [Related]
20. Integrin alpha 11 regulates IGF2 expression in fibroblasts to enhance tumorigenicity of human non-small-cell lung cancer cells.
Zhu CQ; Popova SN; Brown ER; Barsyte-Lovejoy D; Navab R; Shih W; Li M; Lu M; Jurisica I; Penn LZ; Gullberg D; Tsao MS
Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11754-9. PubMed ID: 17600088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]